Try The Drug Club risk-free for 30 days Trial terms

Nicardipine — Membership Pricing

Nicardipine is not confirmed for no-additional-cost pricing. Membership pricing may be available; confirm the price with the dispensing pharmacy.

Nicardipine Pricing

Pricing typePrice
TheDrugClubMembership pricing may be available
Typical Retail$31.00

Membership pricing may be available; confirm the price with the dispensing pharmacy.

About Nicardipine

Nicardipine is a prescription medication. Ask your doctor if Nicardipine is right for you.

How to Check Nicardipine Pricing

  1. Join TheDrugClub for $19.95/month
  2. Receive your member card by email
  3. Present your card at a participating pharmacy
  4. Check active-formulary eligibility or available membership pricing

Nicardipine at Participating Pharmacies

Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.

Other medications in Heart & Cardiovascular

What Nicardipine is approved for (FDA label)

I. Stable Angina Nicardipine hydrochloride capsules are indicated for the management of patients with chronic stable angina (effort-associated angina). Nicardipine hydrochloride capsules may be used alone or in combination with beta-blockers. II. Hypertension Nicardipine hydrochloride capsules are indicated for the treatment of hypertension. Nicardipine hydrochloride capsules may be used alone or in combination with other antihypertensive drugs. In administering nicardipine it is important to be aware of the relatively large peak to trough differences in blood pressure effect (see DOSAGE AND ADMINISTRATION ).

Source: Read the full FDA label on DailyMed. Label effective date: October 3, 2024.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Nicardipine (FDA label)

In multiple-dose US and foreign controlled short-term (up to 3 months) studies 1,910 patients received nicardipine hydrochloride alone or in combination with other drugs. In these studies adverse events were reported spontaneously; adverse experiences were generally not serious but occasionally required dosage adjustment and about 10% of patients left the studies prematurely because of them. Peak responses were not observed to be associated with adverse effects during clinical trials, but physicians should be aware that adverse effects associated with decreases in blood pressure (tachycardia, hypotension, etc.) could occur around the time of the peak effect. Most adverse effects were expected consequences of the vasodilator effects of nicardipine hydrochloride.

Source: FDA prescribing information (DailyMed). Set ID: 79304b0f-53d3-4065-8c81-7031d1141694. SPL document ID: 8f57d96f-7e5b-409f-9e21-c3ed67369716. Label effective date: October 3, 2024. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Nicardipine (FDA label)

Nicardipine hydrochloride capsules are contraindicated in patients with hypersensitivity to the drug. Because part of the effect of nicardipine hydrochloride capsules are secondary to reduced afterload, the drug is also contraindicated in patients with advanced aortic stenosis. Reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance.

Source: FDA prescribing information (DailyMed). Set ID: 79304b0f-53d3-4065-8c81-7031d1141694. SPL document ID: 8f57d96f-7e5b-409f-9e21-c3ed67369716. Label effective date: October 3, 2024. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Nicardipine (FDA label)

Beta-Blockers In controlled clinical studies, adrenergic beta-receptor blockers have been frequently administered concomitantly with nicardipine hydrochloride. The combination is well tolerated. Cimetidine Cimetidine increases nicardipine hydrochloride plasma levels. Patients receiving the two drugs concomitantly should be carefully monitored. Digoxin Some calcium blockers may increase the concentration of digitalis preparations in the blood. Nicardipine hydrochloride usually does not alter the plasma levels of digoxin; however, serum digoxin levels should be evaluated after concomitant therapy with nicardipine hydrochloride is initiated. Maalox ® 2 Co-administration of Maalox TC had no effect on nicardipine hydrochloride absorption. Fentanyl Anesthesia Severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta-blocker and a calcium channel blocker. Even though such interactions were not seen during clinical studies with nicardipine hydrochloride, an increased volume of circulating fluids might be required if such an interaction were to occur.

Source: FDA prescribing information (DailyMed). Set ID: 79304b0f-53d3-4065-8c81-7031d1141694. SPL document ID: 8f57d96f-7e5b-409f-9e21-c3ed67369716. Label effective date: October 3, 2024. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Start Your Risk-Free Trial
Start Your Risk-Free Trial